Actinium Pharmaceuticals ... (ATNM)
1.79
-0.10 (-5.29%)
At close: Mar 28, 2025, 3:59 PM
1.80
0.35%
After-hours: Mar 28, 2025, 07:55 PM EDT
Actinium Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -48.82M | -33.02M | -24.77M | -22.21M | -21.9M | -23.65M | -26.6M | -24.32M | -21.03M | -24.69M | -10.77M | -8.36M | 10.29K | 1.67K | -22.33K | -31.24K | -14.8K | -18.4K |
| Depreciation & Amortization | 790K | 699K | 524K | 447K | 420.09K | 50.72K | 55.94K | 77.52K | 53.47K | 37.91K | 1.56K | 581.00 | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 3.84M | 2.79M | 1.69M | 1.25M | 1.29M | 1.8M | 3.49M | 4.3M | 7.06M | 6.28M | 657.81K | 2.22M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -972K | 33.57M | 495K | -846K | -21.45K | 100.03K | 1.4M | -1.03M | -27.27K | -60.72K | 156.58K | 247.26K | 3.94K | 5.97K | 2.41K | 7.28K | 2.81K | 870.00 |
| Other Non-Cash Items | n/a | -402K | 1.55M | 2.4M | 3.39M | 766.6K | -304.12K | -2.53M | -3.81M | 2.21M | 4.18M | 342.46K | n/a | n/a | -1 | n/a | n/a | n/a |
| Deferred Income Tax | n/a | 402K | -1.55M | -2.4M | -3.39M | n/a | n/a | -6.83M | -7.06M | -6.28M | -653.69K | -685.42K | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -3.15M | 38.17M | 1.69M | -1.1M | -1.28M | 1.23M | 1.8M | 1.69M | -821.22K | 1.81M | -361.51K | 581.52K | -9.75K | 6.16K | 3.55K | 17.28K | -692 | 4.37K |
| Operating Cash Flow | -47.34M | 8.64M | -20.87M | -21.62M | -21.46M | -20.57M | -21.55M | -20.79M | -18.54M | -14.35M | -6.29M | -5.21M | 539.00 | 7.83K | -18.78K | -13.96K | -15.49K | -14.03K |
| Capital Expenditures | -153K | -366K | -133K | -253K | -63.89K | -96.09K | -24.74K | -59.96K | -47.79K | -151.69K | -16.59K | -2.36K | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -356.21K | -49.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -356.21K | -49.86K | n/a | -34.73K | -16.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -153K | -366K | -133K | -253K | -63.89K | -96.09K | -380.95K | -109.82K | -47.79K | -186.42K | -16.59K | -2.36K | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | -4K | -49K | -85K | -460K | -322K | n/a | n/a | -265.69K | -283.55K | -161.84K | -140K | n/a | 645.89K | n/a | 18.69K | 13.87K | 21.46K | 14.5K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | -1K | -1.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 524K | n/a | 6K | 48K | 1.5M | 4.85K | n/a | 18.11K | 173.62K | 435.15K | 3.48M | n/a | -6.03M | -9.81K | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 14.87M | 23.11M | 35.22M | 76.18M | 17.11M | 16.98M | 18.81M | 15.78M | 37.53M | 15.71M | 6.22M | 5.13M | -539 | -9.81K | 18.69K | 13.87K | 21.46K | 14.5K |
| Net Cash Flow | -32.62M | 31.39M | 14.22M | 54.31M | -4.41M | -3.69M | -3.12M | -5.12M | 18.94M | 1.17M | -85.3K | -85.13K | n/a | -1.97K | -96 | -96 | 5.97K | 466.00 |
| Free Cash Flow | -47.49M | 8.28M | -21M | -21.87M | -21.53M | -20.67M | -21.58M | -20.85M | -18.59M | -14.5M | -6.31M | -5.22M | 539.00 | 7.83K | -18.78K | -13.96K | -15.49K | -14.03K |